Irisin plays an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, China

Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participa...

Full description

Saved in:
Bibliographic Details
Published inJournal of diabetes investigation Vol. 12; no. 5; pp. 747 - 755
Main Authors He, Xi, Zhang, Qiao, Peng, Nianchun, Hu, Ying, Li, Hong, Chen, Zhengyi, Liu, Ruoyi, Xu, Shujing, Zhang, Miao, He, Juan, Shi, Lixin
Format Journal Article
LanguageEnglish
Published Japan John Wiley & Sons, Inc 01.05.2021
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN2040-1116
2040-1124
2040-1124
DOI10.1111/jdi.13416

Cover

Abstract Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay. Results Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206). Conclusions Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals. This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a predictor of diabetes in prediabetic individuals. We believe that our study makes a significant contribution to the literature, because we found a clear association between serum irisin levels and the outcomes of newly diagnosed prediabetes.
AbstractList Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay. Results Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206). Conclusions Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals. This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a predictor of diabetes in prediabetic individuals. We believe that our study makes a significant contribution to the literature, because we found a clear association between serum irisin levels and the outcomes of newly diagnosed prediabetes.
This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a predictor of diabetes in prediabetic individuals. We believe that our study makes a significant contribution to the literature, because we found a clear association between serum irisin levels and the outcomes of newly diagnosed prediabetes.
Aims/IntroductionTo explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.Materials and MethodsData were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay.ResultsBaseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206).ConclusionsIrisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.
Abstract Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case–control study included 161 participants who developed diabetes mellitus at follow up, and 161 age‐ and sex‐matched controls. The follow‐up study included 86 matched case–control pairs. Fasting serum irisin levels were measured using enzyme‐linked immunosorbent assay. Results Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025–1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511–6.218). The extent of decrease in irisin levels during follow‐up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow‐up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112–12.206). Conclusions Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.AIMS/INTRODUCTIONTo explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case-control study included 161 participants who developed diabetes mellitus at follow up, and 161 age- and sex-matched controls. The follow-up study included 86 matched case-control pairs. Fasting serum irisin levels were measured using enzyme-linked immunosorbent assay.MATERIALS AND METHODSData were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case-control study included 161 participants who developed diabetes mellitus at follow up, and 161 age- and sex-matched controls. The follow-up study included 86 matched case-control pairs. Fasting serum irisin levels were measured using enzyme-linked immunosorbent assay.Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025-1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511-6.218). The extent of decrease in irisin levels during follow-up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow-up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112-12.206).RESULTSBaseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025-1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511-6.218). The extent of decrease in irisin levels during follow-up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow-up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112-12.206).Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.CONCLUSIONSIrisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Data were obtained from the Guiyang subcenter of the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. A total of 2,530 participants had newly diagnosed prediabetes at baseline and completed follow up. The nested 1:1 case-control study included 161 participants who developed diabetes mellitus at follow up, and 161 age- and sex-matched controls. The follow-up study included 86 matched case-control pairs. Fasting serum irisin levels were measured using enzyme-linked immunosorbent assay. Baseline serum irisin levels were higher in the cases than in the controls (P = 0.002); high baseline serum irisin levels were an independent risk factor for the development of diabetes (odds ratio 1.235, 95% confidence interval 1.025-1.488). After adjustment for age, sex, body mass index, glycated hemoglobin (HbA1c), smoking, exercise, and family history of diabetes, subjects in the highest quartile of irisin levels had a higher risk of diabetes than those in the lowest quartile (odds ratio 3.065, 95% confidence interval 1.511-6.218). The extent of decrease in irisin levels during follow-up was greater in the cases than in the controls (P < 0.001). Baseline serum irisin levels were positively correlated with the extent of decrease in irisin during follow-up (r = 0.773, P < 0.001). After adjustment for confounding factors, subjects with a decrease of irisin above the median had much higher risk for diabetes (odds ratio 5.077, 95% confidence interval 2.112-12.206). Irisin might play an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, and can predict the risk for developing diabetes in these individuals.
Author Liu, Ruoyi
Zhang, Miao
Xu, Shujing
He, Xi
Li, Hong
Hu, Ying
Zhang, Qiao
Peng, Nianchun
He, Juan
Chen, Zhengyi
Shi, Lixin
AuthorAffiliation 2 Department of Endocrinology and Metabolism Guizhou Provincial People’s Hospital Guiyang China
1 Department of Endocrinology and Metabolism Affiliated Hospital of Guizhou Medical University Guiyang China
AuthorAffiliation_xml – name: 1 Department of Endocrinology and Metabolism Affiliated Hospital of Guizhou Medical University Guiyang China
– name: 2 Department of Endocrinology and Metabolism Guizhou Provincial People’s Hospital Guiyang China
Author_xml – sequence: 1
  givenname: Xi
  orcidid: 0000-0003-4933-1719
  surname: He
  fullname: He, Xi
  organization: Guizhou Provincial People’s Hospital
– sequence: 2
  givenname: Qiao
  surname: Zhang
  fullname: Zhang, Qiao
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 3
  givenname: Nianchun
  surname: Peng
  fullname: Peng, Nianchun
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 4
  givenname: Ying
  surname: Hu
  fullname: Hu, Ying
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 5
  givenname: Hong
  surname: Li
  fullname: Li, Hong
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 6
  givenname: Zhengyi
  surname: Chen
  fullname: Chen, Zhengyi
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 7
  givenname: Ruoyi
  surname: Liu
  fullname: Liu, Ruoyi
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 8
  givenname: Shujing
  surname: Xu
  fullname: Xu, Shujing
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 9
  givenname: Miao
  surname: Zhang
  fullname: Zhang, Miao
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 10
  givenname: Juan
  surname: He
  fullname: He, Juan
  organization: Affiliated Hospital of Guizhou Medical University
– sequence: 11
  givenname: Lixin
  surname: Shi
  fullname: Shi, Lixin
  email: slx1962@medmail.com.cn
  organization: Affiliated Hospital of Guizhou Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33000530$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1vEzEQhleoiJbQA38AWeICiLT-Wnv3goQClKBKXOBseb2zqSPHXuxdov33OEmJaCUyF3s8z7wav_bz4swHD0XxkuArkuN63dorwjgRT4oLijmeE0L52XFPxHlxmdIa52BVJYR8VpwzlrOS4YvCLqNN1qPe6Skh7ZHd9CEO2g8oBgcol4Y7QGEcTNhAQqFDHrZuQq3VKx8StKiPkJMGhlzOuG5HN-x3N6OdtF-9R4s76_WL4mmnXYLL-3VW_Pzy-cfi6_z2-81y8fF2bgStxJzVWtQct0J2jTRGclyaumtrISre0VbTBpuOCgKaNAyIFJLR3NGVtK1Z2XA2K5YH3Tboteqj3eg4qaCt2h-EuFI6DtY4UFAbYUA2RteM8xpXwOqKGNk2YEiV9WbFu4PW6Hs9bbVzR0GC1c5-le1Xe_sz_OEA92OzgdaAH6J2DyZ4WPH2Tq3Cb1XhqsZ4J_DmXiCGXyOkQW1sMuCc9hDGpCjnsmKiJCyjrx-h6zBGn31VVHAsqvz68iRVUiwkzZNn6tW_cx8H_vtJMvD2AJgYUorQnTTh-hFr7KAHG3ZXtu5Ux9Y6mP4vrb59Wh46_gCdaOqq
CitedBy_id crossref_primary_10_1051_bioconf_202410804002
crossref_primary_10_1016_j_diabres_2023_110642
Cites_doi 10.2337/db17-0002
10.1111/j.1753-0407.2012.00182.x
10.1016/j.metabol.2014.01.005
10.1210/jc.2013-2373
10.1210/jc.2014-2932
10.1056/NEJMoa0908292
10.1111/add.14082
10.1186/1741-7015-11-235
10.3390/cells8101283
10.1016/S2213-8587(14)70144-5
10.1210/jc.2014-1437
10.3389/fphys.2019.00871
10.1038/nrendo.2016.221
10.1111/jdi.12331
10.1155/2019/6737318
10.1016/j.phrs.2018.01.012
10.1111/1753-0407.12256
10.1042/BSR20170213
10.1210/jc.2012-2749
10.1186/s13293-018-0189-3
10.1136/bmj.l4414
10.1016/j.ijcard.2018.05.075
10.1016/j.jdiacomp.2013.03.002
10.1016/j.diabres.2018.03.046
10.1016/j.metabol.2017.05.007
10.1038/s41467-017-01131-0
10.1186/s12933-015-0319-8
10.1001/jama.2013.168118
10.1002/dmrr.3238
10.2337/db13-1106
10.1038/ijo.2015.199
10.1007/s13311-018-0651-2
10.1016/j.metabol.2017.10.011
10.1186/1758-5996-6-133
10.1016/j.amjmed.2014.04.025
10.1042/CS20150009
10.1038/nature10777
10.3945/ajcn.2009.28136
10.1097/MD.0000000000003742
10.1016/S2213-8587(18)30026-3
10.1186/s12933-017-0627-2
10.1002/iub.1511
10.1016/j.metabol.2013.12.007
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
ContentType Journal Article
Copyright 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd
– notice: 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TM
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1111/jdi.13416
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database

MEDLINE - Academic
Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 6
  dbid: BENPR
  name: ProQuest Central (New) (NC LIVE)
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Role of irisin in prediabetes outcomes
EISSN 2040-1124
EndPage 755
ExternalDocumentID oai_doaj_org_article_e9c6ce7bca9344908e3981c7dbec18d9
10.1111/jdi.13416
PMC8089006
33000530
10_1111_jdi_13416
JDI13416
Genre article
Journal Article
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: National Key R&D Program of China
  funderid: 2016YFC0901203; 2017YFC1310700; 2017YFC1310701
– fundername: Special Research Project for Public Welfare Industry, National Health and Family Planning Commission of the People’s Republic of China
  funderid: 201502007
– fundername: Key clinical specialty cultivation project of Guizhou province(2016)
  funderid: SZD‐2016‐01
– fundername: Fund for Less Developed Regions of the National Natural Science Foundation of China
  funderid: 81860161
– fundername: National Key R&D Program of China
  grantid: 2016YFC0901203,
– fundername: Fund for Less Developed Regions of the National Natural Science Foundation of China
  grantid: 81860161
– fundername: National Key R&D Program of China
  grantid: 2017YFC1310700
– fundername: Special Research Project for Public Welfare Industry, National Health and Family Planning Commission of the People's Republic of China
  grantid: 201502007
– fundername: Key clinical specialty cultivation project of Guizhou province(2016)
  grantid: SZD-2016-01
– fundername: National Key R&D Program of China
  grantid: 2017YFC1310701
– fundername: National Key R&D Program of China
  grantid: 2016YFC0901203
– fundername: National Key R&D Program of China
  grantid: 2016YFC0901203; 2017YFC1310700; 2017YFC1310701
– fundername: Key clinical specialty cultivation project of Guizhou province(2016)
  grantid: SZD‐2016‐01
– fundername: Special Research Project for Public Welfare Industry, National Health and Family Planning Commission of the People’s Republic of China
  grantid: 201502007
GroupedDBID ---
05W
0R~
1OC
24P
31~
4.4
50Y
5DZ
5VS
7X7
8-0
8-1
8FI
8FJ
AAHHS
AANHP
AAZKR
ABDBF
ABJNI
ABUWG
ACBWZ
ACCFJ
ACCMX
ACGFO
ACPRK
ACRPL
ACUHS
ACXQS
ACYXJ
ADBBV
ADKYN
ADNMO
ADPDF
ADRAZ
ADZMN
AEEZP
AEGXH
AENEX
AEQDE
AFKRA
AHMBA
AIAGR
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
ASPBG
AVUZU
AVWKF
AZFZN
BAWUL
BCNDV
BDRZF
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
DIK
EBD
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
KQ8
LH4
LW6
M48
MY.
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
RX1
SUPJJ
TEORI
UKHRP
WIN
AAMMB
AAYXX
AEFGJ
AGQPQ
AGXDD
AIDQK
AIDYY
CITATION
PHGZM
PHGZT
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TM
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c6286-39a6940d67fb7cc7405c9fd96684f2da2b0cf261ea1b3e176732a69f52d935b43
IEDL.DBID DOA
ISSN 2040-1116
2040-1124
IngestDate Wed Aug 27 01:00:08 EDT 2025
Wed Oct 01 15:54:47 EDT 2025
Tue Sep 30 16:59:35 EDT 2025
Fri Sep 05 09:11:37 EDT 2025
Fri Jul 25 07:40:29 EDT 2025
Sun Sep 07 03:43:09 EDT 2025
Thu Apr 03 07:05:46 EDT 2025
Thu Apr 24 23:09:10 EDT 2025
Wed Oct 01 03:30:53 EDT 2025
Wed Jan 22 16:30:44 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Prediabetes
Irisin
Diabetes
Language English
License Attribution-NonCommercial-NoDerivs
2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6286-39a6940d67fb7cc7405c9fd96684f2da2b0cf261ea1b3e176732a69f52d935b43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4933-1719
OpenAccessLink https://doaj.org/article/e9c6ce7bca9344908e3981c7dbec18d9
PMID 33000530
PQID 2520672134
PQPubID 1006415
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_e9c6ce7bca9344908e3981c7dbec18d9
unpaywall_primary_10_1111_jdi_13416
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8089006
proquest_miscellaneous_2447836513
proquest_journals_2640682047
proquest_journals_2520672134
pubmed_primary_33000530
crossref_primary_10_1111_jdi_13416
crossref_citationtrail_10_1111_jdi_13416
wiley_primary_10_1111_jdi_13416_JDI13416
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2021
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: May 2021
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Richmond
– name: Hoboken
PublicationTitle Journal of diabetes investigation
PublicationTitleAlternate J Diabetes Investig
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2019; 8
2012; 481
2018; 141
2019; 2019
2017; 8
2015; 6
2013; 27
2018; 129
2019; 10
2017; 66
2015; 100
2018; 267
2019; 366
2016; 95
2006
2010; 362
2020; 36
2015; 129
2014; 63
2016; 15
2017; 73
1998; 15
2018; 6
2018; 9
2014; 127
2014; 2
2013; 11
2017; 37
2013; 98
2017; 16
2018; 113
2017; 13
2013; 310
2016; 40
2010; 91
2012; 4
2014; 6
2016; 8
2014; 99
2018; 15
2016; 68
2018; 79
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
World Health Organization (e_1_2_7_24_1) 2006
e_1_2_7_42_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
References_xml – volume: 79
  start-page: 24
  year: 2018
  end-page: 32
  article-title: Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: a cross sectional and a prospective case‐control study nested in the Normative Aging Study
  publication-title: Metabolism
– volume: 9
  start-page: 28
  year: 2018
  article-title: Sex differences in body composition and association with cardiometabolic risk
  publication-title: Biol Sex Differ
– volume: 10
  start-page: 871
  year: 2019
  article-title: Circulating irisin and myostatin as markers of muscle strength and physical condition in elderly subjects
  publication-title: Front Physiol
– volume: 6
  start-page: 571
  year: 2015
  end-page: 576
  article-title: Irisin levels are associated with urotensin II levels in diabetic patients
  publication-title: J Diabetes Investig
– volume: 100
  start-page: 1289
  year: 2015
  end-page: 1299
  article-title: Serum irisin levels are regulated by acute strenuous exercise
  publication-title: J Clin Endocrinol Metab
– volume: 366
  start-page: l4414
  year: 2019
  article-title: Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow‐up of Whitehall II cohort study
  publication-title: BMJ
– volume: 129
  start-page: 839
  year: 2015
  end-page: 850
  article-title: Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
  publication-title: Clin Sci (Lond)
– volume: 36
  year: 2020
  article-title: Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brain
  publication-title: Diabetes Metab Res Rev
– volume: 91
  start-page: 7
  year: 2010
  end-page: 15
  article-title: Racial differences in abdominal depot‐specific adiposity in white and African American adults
  publication-title: Am J Clin Nutr
– volume: 11
  start-page: 235
  year: 2013
  article-title: Irisin and exercise training in humans ‐ results from a randomized controlled training trial
  publication-title: BMC Med
– volume: 40
  start-page: 443
  year: 2016
  end-page: 451
  article-title: Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway
  publication-title: Int J Obes (Lond)
– volume: 141
  start-page: 10
  year: 2018
  end-page: 17
  article-title: High irisin levels are associated with better glycemic control and bone health in children with type 1 diabetes
  publication-title: Diabetes Res Clin Pract
– volume: 13
  start-page: 324
  year: 2017
  end-page: 337
  article-title: Physiology and role of irisin in glucose homeostasis
  publication-title: Nat Rev Endocrinol
– volume: 8
  start-page: 1283
  year: 2019
  article-title: Increased expression of meteorin‐like hormone in type 2 diabetes and obesity and its association with irisin
  publication-title: Cells
– volume: 310
  start-page: 948
  year: 2013
  end-page: 959
  article-title: Prevalence and control of diabetes in Chinese adults
  publication-title: JAMA
– volume: 63
  start-page: 514
  year: 2014
  end-page: 525
  article-title: Irisin stimulates browning of white adipocytes through mitogen‐activated protein kinase p38 MAP kinase and ERK MAP kinase signaling
  publication-title: Diabetes
– volume: 8
  start-page: 56
  year: 2016
  end-page: 62
  article-title: Lower irisin level in patients with type 2 diabetes mellitus: a case‐control study and meta‐analysis
  publication-title: J Diabetes
– volume: 15
  start-page: 9
  year: 2016
  article-title: The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
  publication-title: Cardiovasc Diabetol
– volume: 63
  start-page: 574
  year: 2014
  end-page: 583
  article-title: Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels
  publication-title: Metabolism
– volume: 98
  start-page: 4899
  year: 2013
  end-page: 4907
  article-title: Circulating irisin in relation to insulin resistance and the metabolic syndrome
  publication-title: J Clin Endocrinol Metab
– volume: 95
  year: 2016
  article-title: High serum irisin level as an independent predictor of diabetes mellitus: a longitudinal population‐based study
  publication-title: Medicine (Baltimore)
– volume: 113
  start-page: 719
  year: 2018
  end-page: 728
  article-title: Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002–14: emerging disparities in vulnerable populations
  publication-title: Addiction
– volume: 6
  start-page: 133
  year: 2014
  article-title: Circulating levels of irisin in middle‐aged first‐degree relatives of type 2 diabetes mellitus — correlation with pancreatic β‐cell function
  publication-title: Diabetol Metab Syndr
– volume: 98
  start-page: E769
  year: 2013
  end-page: E778
  article-title: Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
  publication-title: J Clin Endocrinol Metab
– volume: 37
  start-page: BSR20170213
  year: 2017
  article-title: The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients
  publication-title: Biosci Rep
– volume: 99
  start-page: E2154
  year: 2014
  end-page: E2161
  article-title: Exercise‐induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation
  publication-title: J Clin Endocrinol Metab
– volume: 2019
  start-page: 6737318
  year: 2019
  article-title: Association between irisin, hs‐CRP, and metabolic status in children and adolescents with type 2 diabetes mellitus
  publication-title: Mediators Inflamm
– volume: 362
  start-page: 1090
  year: 2010
  end-page: 1101
  article-title: Prevalence of diabetes among men and women in China
  publication-title: N Engl J Med
– volume: 66
  start-page: 2849
  year: 2017
  end-page: 2856
  article-title: The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β‐cell survival and insulin secretion
  publication-title: Diabetes
– volume: 4
  start-page: 172
  year: 2012
  end-page: 173
  article-title: Reaction Study Group. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study
  publication-title: J Diabetes
– volume: 8
  start-page: 1104
  year: 2017
  article-title: Irisin is a pro‐myogenic factor that induces skeletal muscle hypertrophy and rescues denervation‐induced atrophy
  publication-title: Nat Commun
– volume: 129
  start-page: 44
  year: 2018
  end-page: 55
  article-title: A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: an introductory review
  publication-title: Pharmacol Res
– volume: 63
  start-page: 520
  year: 2014
  end-page: 531
  article-title: Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight‐lowering program in obese patients
  publication-title: Metabolism
– volume: 15
  start-page: 539
  year: 1998
  end-page: 553
  article-title: Diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
  publication-title: Diabet Med
– volume: 2
  start-page: 969
  year: 2014
  end-page: 979
  article-title: Diabetes in China: a societal solution for a personal challenge
  publication-title: Lancet Diabetes Endocrinol
– volume: 481
  start-page: 463
  year: 2012
  end-page: 468
  article-title: A PGC1‐α‐dependent myokine that drives brown‐fat‐like development of white fat and thermogenesis
  publication-title: Nature
– year: 2006
– volume: 15
  start-page: 1158
  year: 2018
  end-page: 1167
  article-title: Decreased concentration of irisin is associated with poor functional outcome in ischemic stroke
  publication-title: Neurotherapeutics
– volume: 27
  start-page: 365
  year: 2013
  end-page: 369
  article-title: Lower circulating irisin is associated with type 2 diabetes mellitus
  publication-title: J Diabetes Complications
– volume: 73
  start-page: 100
  year: 2017
  end-page: 108
  article-title: Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents
  publication-title: Metabolism
– volume: 68
  start-page: 544
  year: 2016
  end-page: 556
  article-title: Circulating serum irisin levels in obesity and type 2 diabetes mellitus
  publication-title: IUBMB Life
– volume: 267
  start-page: 177
  year: 2018
  end-page: 182
  article-title: Relationship of serum irisin levels to prevalence and progression of coronary artery calcification: a prospective, population‐based study
  publication-title: Int J Cardiol
– volume: 127
  start-page: 888
  year: 2014
  end-page: 890
  article-title: Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity
  publication-title: Am J Med
– volume: 16
  start-page: 147
  year: 2017
  article-title: Plasma irisin is elevated in type 2 diabetes and is associated with increased E‐selectin levels
  publication-title: Cardiovasc Diabetol
– volume: 6
  start-page: 647
  year: 2018
  end-page: 658
  article-title: The physiology of endocrine systems with ageing
  publication-title: Lancet Diabetes Endocrinol
– ident: e_1_2_7_28_1
  doi: 10.2337/db17-0002
– ident: e_1_2_7_22_1
  doi: 10.1111/j.1753-0407.2012.00182.x
– ident: e_1_2_7_41_1
  doi: 10.1016/j.metabol.2014.01.005
– ident: e_1_2_7_16_1
  doi: 10.1210/jc.2013-2373
– volume-title: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation
  year: 2006
  ident: e_1_2_7_24_1
– ident: e_1_2_7_34_1
  doi: 10.1210/jc.2014-2932
– ident: e_1_2_7_26_1
  doi: 10.1056/NEJMoa0908292
– ident: e_1_2_7_25_1
  doi: 10.1111/add.14082
– ident: e_1_2_7_33_1
  doi: 10.1186/1741-7015-11-235
– ident: e_1_2_7_15_1
  doi: 10.3390/cells8101283
– ident: e_1_2_7_2_1
  doi: 10.1016/S2213-8587(14)70144-5
– ident: e_1_2_7_6_1
  doi: 10.1210/jc.2014-1437
– ident: e_1_2_7_40_1
  doi: 10.3389/fphys.2019.00871
– ident: e_1_2_7_21_1
  doi: 10.1038/nrendo.2016.221
– ident: e_1_2_7_46_1
  doi: 10.1111/jdi.12331
– ident: e_1_2_7_12_1
  doi: 10.1155/2019/6737318
– ident: e_1_2_7_32_1
  doi: 10.1016/j.phrs.2018.01.012
– ident: e_1_2_7_11_1
  doi: 10.1111/1753-0407.12256
– ident: e_1_2_7_45_1
  doi: 10.1042/BSR20170213
– ident: e_1_2_7_10_1
  doi: 10.1210/jc.2012-2749
– ident: e_1_2_7_31_1
  doi: 10.1186/s13293-018-0189-3
– ident: e_1_2_7_27_1
  doi: 10.1136/bmj.l4414
– ident: e_1_2_7_36_1
  doi: 10.1016/j.ijcard.2018.05.075
– ident: e_1_2_7_44_1
  doi: 10.1016/j.jdiacomp.2013.03.002
– ident: e_1_2_7_14_1
  doi: 10.1016/j.diabres.2018.03.046
– ident: e_1_2_7_17_1
  doi: 10.1016/j.metabol.2017.05.007
– ident: e_1_2_7_39_1
  doi: 10.1038/s41467-017-01131-0
– ident: e_1_2_7_9_1
  doi: 10.1186/s12933-015-0319-8
– ident: e_1_2_7_3_1
  doi: 10.1001/jama.2013.168118
– ident: e_1_2_7_29_1
  doi: 10.1002/dmrr.3238
– ident: e_1_2_7_5_1
  doi: 10.2337/db13-1106
– ident: e_1_2_7_8_1
  doi: 10.1038/ijo.2015.199
– ident: e_1_2_7_35_1
  doi: 10.1007/s13311-018-0651-2
– ident: e_1_2_7_20_1
  doi: 10.1016/j.metabol.2017.10.011
– ident: e_1_2_7_42_1
  doi: 10.1186/1758-5996-6-133
– ident: e_1_2_7_37_1
  doi: 10.1016/j.amjmed.2014.04.025
– ident: e_1_2_7_7_1
  doi: 10.1042/CS20150009
– ident: e_1_2_7_4_1
  doi: 10.1038/nature10777
– ident: e_1_2_7_30_1
  doi: 10.3945/ajcn.2009.28136
– ident: e_1_2_7_19_1
  doi: 10.1097/MD.0000000000003742
– ident: e_1_2_7_38_1
  doi: 10.1016/S2213-8587(18)30026-3
– ident: e_1_2_7_13_1
  doi: 10.1186/s12933-017-0627-2
– ident: e_1_2_7_43_1
  doi: 10.1002/iub.1511
– ident: e_1_2_7_18_1
  doi: 10.1016/j.metabol.2013.12.007
– ident: e_1_2_7_23_1
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
SSID ssj0000388667
Score 2.2355964
Snippet Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained from the...
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Data were obtained from the Guiyang subcenter of the Risk Evaluation of...
Aims/IntroductionTo explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.Materials and MethodsData were obtained from the...
To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes.AIMS/INTRODUCTIONTo explore the potential role of irisin in the outcomes...
This is the first longitudinal study to investigate the potential role of irisin in the outcomes of newly diagnosed prediabetes and whether it can be a...
Abstract Aims/Introduction To explore the potential role of irisin in the outcomes of newly diagnosed prediabetes. Materials and Methods Data were obtained...
SourceID doaj
unpaywall
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 747
SubjectTerms Aged
Alcohol
Autoimmune diseases
Blood pressure
Body mass index
Cardiovascular disease
Case-Control Studies
China - epidemiology
Cholesterol
Creatinine
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - epidemiology
Enzymes
Epidemiology
Fasting - blood
Female
Fibronectins - blood
Follow-Up Studies
Glucose
Hemoglobin
High density lipoprotein
Humans
Hypertension
Insulin resistance
Irisin
Laboratories
Longitudinal Studies
Male
Middle Aged
Odds Ratio
Original
Plasma
Prediabetes
Prediabetic State - blood
Prediabetic State - diagnosis
Proteins
Regression analysis
Risk Assessment
Risk Factors
Smoking
Variance analysis
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8SZQkHkceiCQ-BmfEK9SKpUTlfYWOX6USMEJuxuh_ffYXm9QxNJblJlIsT1jf_aMvwHglaVUCkVlbnFhciKRzoUhLOcFshUikpB4Q-7sGzs5J6cLukgHbquUVrmbE-NErXsVzsjfIhqIxgP_2LvhVx6qRoXoaiqhcRVcKz1UCVbNF3w6YwlMJywWkUUhcc67NUvkQjGZR7dvAp0Zmy1Jkbl_H9z8N2vyxugGufktu26ObOPSdHwb3EqYEr7fGsEdcMW4u-D6WYqa3wNtKCPfOjh0crOC0sH2Z0Tdbg1DciH0Ig8DYT-ufVeYFewt9GC720C9zcMzGg5LszulDeqRtSM-fRnbjXQXr2EsxH0fnB9__v7xJE8lFnIV7qTmWEgmSKEZtw1Xinv4poTVfg9UEYu0RE2hrN9kGVk22JSccYz8F5YiLTBtCH4ADlzvzCMAtTSS8qaxyGrSWFlhy3VphaBaNsjgDBzterlWiX88lMHo6mkfots6DkgGXkyqw5Z0Y5_ShzBUk0LgyY4v-uVFndyuNkIxZXijpMAkxDgNFlWpuPamW1ZaZOBwN9B1ct5V_dfU9ouZB0EeOBGegeeT2HtlCLVIZ_rR6xASrsfQ0jf74dZsph_FON6ALjLAZwY1a8lc4tofkfm7Kirhp8kMvJxM77IOOopG-X-N-vTT1_jw-PJueAJuopDKE_M8D8HBejmapx6LrZtn0eH-AAmaMnI
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLZKkYALYidQkFkOPZAq8RofEGIrpdJwYqTeIq8lUkiGmYkg_x7bk0SKGDhxi-JnKX7-bH-On78HwEtHqRSaytThzKZEIpMKS1jKM-QKRCQh8Ybc4gs7W5LzC3pxAMYcm4MDN3u3diGf1HJdn_z60b_xA_71FJVjqpOgS8augKt-QUIB3IuB5ccJGRcFi7lkUYif81XYoDE0qz1bmaKA_z7W-Wfw5PWuWcn-p6zrOcGNK9TpLXBzoJbw7Q4Lt8GBbe6Aa4vh8PwuqEI2-aqBq1r2GygbWH2P7W62MMQYQl_k2SBsu61Hod3A1kHPueseml04njVwtbbjz9pgHsU74tOnruplc_kKxnzc98Dy9OPX92fpkGkh1eFqaoqFZIJkhnGnuNbcszgtnPFboYI4ZCRSmXZ-r2VlrrDNOeMY-RqOIiMwVQTfB4dN29iHABppJeVKOeQMUU4W2HGTOyGokQpZnIDj0culHmTIQzaMupy2I6YqY4ck4Plkutppb-wzehe6ajIIctnxRbu-LIfRV1qhmbZcaSkwCUedFosi19x4BOeFEQk4Gju6HCFYIhqk7YPi3f5i5rmQ50-EJ-DZVOwHZzhxkY1tO29DSLglQ3Pf7Ac72EwfinG8CJ0lgM8ANWvJvKSpvkUB8CIrhJ8tE_Bigt6_HHQcQfl3i_L8w-f48Oh_-PIxuIFC3E8MCj0Ch9t1Z5944rZVT-Ow_A1A5UG_
  priority: 102
  providerName: Scholars Portal
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgK0EvvB-Bgszj0ANZEtuJ42N5lFKpFQdWKqfgZ4kakmg3EVp-PbaTDQosCImbFY-T2JlxPtsz3wDw3CQJZzLhocGRDglHKmSapCGNkMkQ4YT4CLmT0_RoQY7PkrMhz6mLhen5IcYNN2cZfr52Bt4o08_zL0d_HFXMHSNZehnspO6EaQZ2FqcfDj65lHLOV84KpT_LiAzcQpO2kz-SJ-7fhjZ_d5q82lUNX3_jZTkFtv7PdHgdfN70qXdIuZh3rZjL77_QPf5Hp2-AawNqhQe9mt0El3R1C1w5Gc7lb4PCJaovKtiUfL2CvILFV4_rqxY690VoqyzQhHXX2gfqFawNtHC-XEPVe_ppBZul3uwDO3HPC-JL77pizavzF9Cn-r4DFodvP74-CockDqF0Ua8hZjxlJFIpNYJKSS1AlMwou8rKiEGKIxFJY5dxmscC65imFCPbwiRIMZwIgu-CWVVX-j6AimueUCEMMooIwzNsqIoNY4niAmkcgP3Nh8zlwHDuEm2U-bjSUUXuhy4AT0fRpqf12Cb0ymnDKOCYuP2FenmeD4adayZTqamQnGHiTlE1ZlksqbLGEWeKBWBvo0v5MD2scpQ41nxHpre9OrUwy0IzQgPwZKy2du8Oc3il687KEOICcJLYdvter5nji2LsY6yjANCJzk56Mq2pii-eWzyLMmYn4gA8G7X7bwO075X1zxL58Zv3vvDgn274EOwi5zPkHUr3wKxddvqRBX2teDwY9g9g5FYv
  priority: 102
  providerName: Unpaywall
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9QwFLZKkaAXxN5AQWY59EBQ4jUWJ7ZSKhVxoFJvkdcSaXBGMxOh-ffYziIiBsTNip-l2H7P_my_9z0AXjpKpdBU5g4XNicSmVxYwnJeIFchIglJEXLnX9jpBTm7pJd74M0YC9PzQ0wXbtEy0nodDVyq9e9GbprXkY2MXQPXy7jrR1pn8nW6YIk0JyxlkEXRay40YgOzUPLkGVvP9qNE278La_7pMnmz80u5_SkXizmsTfvSyW1wawCU8G2vAXfAnvV3wY3z4cn8HmhiDvnGw-VCbtdQetj8SJDbb2D0LIShKmBA2HabMAB2DVsHA9JebKHpnfCsgcuVHa9oo3ii7EilT12zlf7qFUxZuO-Di5OP396f5kN-hVzHgNQcC8kEKQzjTnGtecBuWjgTDkAVcchIpArtwgnLylJhW3LGMQotHEVGYKoIfgD2fevtIYBGWkm5Ug45Q5STFXbclE4IaqRCFmfgeBzlWg_k4zEHxqKeDiGmqdOEZOD5JLrsGTd2Cb2LUzUJRJLs9KFdXdWDzdVWaKYtV1oKTOIDp8WiKjU3QW_LyogMHI0TXQ-Wu64RjYT2kedudzULCCigJsIz8GyqDiYZ31mkt20XZAiJsTG0DN1-2KvN9KMYp_DnIgN8plCznsxrfPM90X5XRSXCGpmBF5Pq_WuAjpNS_l2iPvvwORUe_b_oY3CAok9Pcvg8AvubVWefBFC2UU-T8f0C04Yybg
  priority: 102
  providerName: Wiley-Blackwell
Title Irisin plays an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, China
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdi.13416
https://www.ncbi.nlm.nih.gov/pubmed/33000530
https://www.proquest.com/docview/2520672134
https://www.proquest.com/docview/2640682047
https://www.proquest.com/docview/2447836513
https://pubmed.ncbi.nlm.nih.gov/PMC8089006
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.13416
https://doaj.org/article/e9c6ce7bca9344908e3981c7dbec18d9
UnpaywallVersion publishedVersion
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: KQ8
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: KQ8
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCO Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: ABDBF
  dateStart: 20120401
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: 7X7
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central (New) (NC LIVE)
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: BENPR
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 20250630
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: M48
  dateStart: 20100501
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVWIB
  databaseName: KBPluse Wiley Online Library: Open Access
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: AVUZU
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2040-1124
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000388667
  issn: 2040-1116
  databaseCode: 24P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgkYAL4k1gqczjsAcCie3E8XEXdllWalUhKpVT5CdECmm1bYT67xk7abQVBS5cLMueKLE9tj_HM98g9NplmRQ6k7GjiY2ZJCYWluUxT4grCJOMBQ-58SQ_n7GLeTa_EurL24R19MBdx72zQufacqWloMzfUlkqilRzAy9PCxNc92Abu3KYCmswLYo8hI8l3mQOJnTe0woFMx5TvfVEZvnOZhQ4-_cBzd_tJW-1zVJufsq63sW0YVM6u4vu9GgSH3etuIeu2eY-ujnu78sfoMoHkK8avKzlZoVlg6sfAW83a-zNCjFUAQDEi3YNimdXeOEwwOx6g01ngWcNXl7a7f9ZLx74OkLuY1ttZPPtDQ4huB-i2dnpl_fncR9cIdbeGzWmQuaCJSbnTnGtOQA3LZyB00_BHDGSqEQ7OF5ZmSpqU55zSuAJlxEjaKYYfYQOmkVjnyBspJUZV8oRZ5hysqCOm9QJkRmpiKUROtr2cql75nEfAKMuhxOIqcowIBF6OYguO7qNfUInfqgGAc-QHQpAb8peb8p_6U2EDrcDXfbTdlWSzLPZe5K7_dU5wB-ATIxH6MVQDfPRX7LIxi5akGHMO8ZkKTT7cac2w4dSGnyfkwjxHYXaacluTVN9D5zfRVIIWCAj9GpQvb910FFQyj9LlBcfPoXM0__Rl8_QbeJNfYId6CE6WF-29jlgtbUaoeuETSHlcz5CN05OJ9PPozBVIR2zAspmk-nx119X5kHt
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSgXxJtAAfOSeiCQ2E4cHxACStltuz210t6C40eJtCTL7kbV_il-Ix5vErRi6a23KJ5E8Xg8-WzPfIPQa5skUqhEhpZGJmSS6FAYloY8IjYjTDLmM-RGJ-ngjB2Ok_EW-t3lwkBYZecTvaPWtYI98vckAaJx4B_7OP0VQtUoOF3tSmiszOLILC_ckm3-YbjvxvcNIQdfT78MwraqQKggDTOkQqaCRTrltuBKcYdYlLDawf6MWaIlKSJl3brCyLigJuYpp8Q9YROiBU0KRt17r6HrjEYMuPr5mPd7OsCskvqitQQC9ZwbSVsyIx88pMt3QJ-Wrv0CfaWATfD23yjNnaaayuWFnEzWkbT_FR7cRrdaDIs_rYzuDtoy1V10Y9Se0t9DJZStLys8ncjlHMsKlz89yq8WGIIZsWtysBPXzcKp3sxxbbED95Ml1qu4P6PxdGa6XWEQ9ywh_upbUy5ldf4W-8Lf99HZlSj_Adqu6so8QlhLIxNeFJZYzQorM2q5jq0QiZYFMTRAe52Wc9XynUPZjUner3t0mfsBCdDLXnS6IvnYJPQZhqoXAF5uf6OeneftNM-NUKkyvFBSUAZnqoaKLFZcu6kSZ1oEaLcb6Lx1FvP8r2lvbk4d6HJAjfEAveibnReAox1ZmbpxMoxBOk4Su24_XJlN_6GU-ozrKEB8zaDWerLeUpU_PNN4FmXCueUAvepN7zIF7Xmj_L9Efrg_9BePL1fDc7QzOB0d58fDk6Mn6CaBMCIfY7qLthezxjx1OHBRPPOTD6PvVz3b_wDOmm5c
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkQoXxJtAAfOSeiA0sZ04PiAELEu3pRUHKu0tOH6USCFZ9qFq_xq_Do83CVqx9NZbtJ6NEs8jY_ubbxB6aZNECpXI0NLIhEwSHQrD0pBHxGaEScZ8hdzxSXpwyg7HyXgL_e5qYQBW2cVEH6h1o2CPfJ8kQDQO_GP7toVFfB0M301-hdBBCk5au3YaKxM5Mstzt3ybvR0NnK5fETL89O3jQdh2GAgVlGSGVMhUsEin3BZcKe6yFyWsdkuAjFmiJSkiZd0aw8i4oCbmKafE_cMmRAuaFIy6-15BVzllFOBkfMz7_R1gWUl9A1sCoD0XUtKW2MgDiXT5BqjU0rXPoe8asCnV_RexeW1RT-TyXFbVelbtP4vDm-hGm8_i9ysDvIW2TH0b7Ry3J_Z3UAkt7MsaTyq5nGFZ4_Knz_jrOQZgI3ZDLgXFzWLu1GBmuLHYJfrVEusVBtBoPJmabocYxD1jiL_6vCiXsj57jX0T8Lvo9FIm_x7arpvaPEBYSyMTXhSWWM0KKzNquY6tEImWBTE0QHvdLOeq5T6HFhxV3q-BdJl7hQToeS86WRF-bBL6AKrqBYCj2__QTM_y1uVzI1SqDC-UFJTB-aqhIosV185t4kyLAO12is7bwDHL_5r55uHUJWAuaWM8QM_6YRcR4JhH1qZZOBnGoDQnid1r31-ZTf-glPrq6yhAfM2g1t5kfaQuf3jW8SzKhAvRAXrRm95FE7TnjfL_EvnhYOQvHl48DU_RjvPz_Mvo5OgRuk4AUeThprtoez5dmMcuJZwXT7zvYfT9sp39DxZccpc
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgK0EvvB-Bgszj0ANZEtuJ42N5lFKpFQdWKqfgZ4kakmg3EVp-PbaTDQosCImbFY-T2JlxPtsz3wDw3CQJZzLhocGRDglHKmSapCGNkMkQ4YT4CLmT0_RoQY7PkrMhz6mLhen5IcYNN2cZfr52Bt4o08_zL0d_HFXMHSNZehnspO6EaQZ2FqcfDj65lHLOV84KpT_LiAzcQpO2kz-SJ-7fhjZ_d5q82lUNX3_jZTkFtv7PdHgdfN70qXdIuZh3rZjL77_QPf5Hp2-AawNqhQe9mt0El3R1C1w5Gc7lb4PCJaovKtiUfL2CvILFV4_rqxY690VoqyzQhHXX2gfqFawNtHC-XEPVe_ppBZul3uwDO3HPC-JL77pizavzF9Cn-r4DFodvP74-CockDqF0Ua8hZjxlJFIpNYJKSS1AlMwou8rKiEGKIxFJY5dxmscC65imFCPbwiRIMZwIgu-CWVVX-j6AimueUCEMMooIwzNsqIoNY4niAmkcgP3Nh8zlwHDuEm2U-bjSUUXuhy4AT0fRpqf12Cb0ymnDKOCYuP2FenmeD4adayZTqamQnGHiTlE1ZlksqbLGEWeKBWBvo0v5MD2scpQ41nxHpre9OrUwy0IzQgPwZKy2du8Oc3il687KEOICcJLYdvter5nji2LsY6yjANCJzk56Mq2pii-eWzyLMmYn4gA8G7X7bwO075X1zxL58Zv3vvDgn274EOwi5zPkHUr3wKxddvqRBX2teDwY9g9g5FYv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Irisin+plays+an+important+role+in+the+outcomes+of+newly+diagnosed+prediabetes+in+adults+in+Guiyang%2C+China&rft.jtitle=Journal+of+diabetes+investigation&rft.au=Xi+He&rft.au=Qiao+Zhang&rft.au=Nianchun+Peng&rft.au=Ying+Hu&rft.date=2021-05-01&rft.pub=Wiley&rft.issn=2040-1116&rft.eissn=2040-1124&rft.volume=12&rft.issue=5&rft.spage=747&rft.epage=755&rft_id=info:doi/10.1111%2Fjdi.13416&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e9c6ce7bca9344908e3981c7dbec18d9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2040-1116&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2040-1116&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2040-1116&client=summon